S2 Ep9: Is It Time to Give Up On Biosimilars? - a podcast by Not So Different: a Podcast from The Center for Biosimilars
from 2019-04-28T05:00
::
::
In a 2-part proposal published on the Health Affairs blog, a team of authors argued that efforts to induce lower prices through competition via biosimilars will inevitably fail. Instead, they write, prices for innovator biologics should be regulated by the US government after patent expiry.This week on the podcast, we’re talking with Mark Trusheim, MS, one of the authors of the proposal.
Further episodes of Not So Different: a Podcast from The Center for Biosimilars
Further podcasts by Not So Different: a Podcast from The Center for Biosimilars
Website of Not So Different: a Podcast from The Center for Biosimilars